Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for constructing a cell model for screening antioxidant drugs based on protein misfolding

A cell model and misfolding technology, applied in the field of cell biology, can solve problems such as misfolding and inability to quantitatively evaluate, and achieve high chromosome integration, sensitivity to antioxidant drugs, and stable genetic traits

Active Publication Date: 2021-07-02
SHANXI UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Aiming at the defect that protein misfolding cannot be quantitatively evaluated in real time in living cells, the present invention provides a method for constructing a cell model for screening antioxidant drugs based on protein misfolding

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for constructing a cell model for screening antioxidant drugs based on protein misfolding
  • A method for constructing a cell model for screening antioxidant drugs based on protein misfolding
  • A method for constructing a cell model for screening antioxidant drugs based on protein misfolding

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1: Packaging lentiviral particles

[0021] The lentiviral system includes three plasmids: Plvx-IRES-Puro plasmid expressing reporter gene ( figure 1 ), packaging plasmid psPAX2 ( figure 2 ), envelope protein particle pMD2.G ( image 3 ). Among them, the Plvx-IRES-Puro plasmid contains the puromycin resistance gene and the ampicillin resistance gene, the packaging plasmid psPAX2 contains the gag gene of the HIV virus, which encodes the main structural protein of the virus, and the envelope protein particle pMD2.G contains the herpes simplex The derived VSV-G gene provides the required envelope protein for viral packaging.

[0022] Reporter gene construction: use the known eGFP-COMP fusion gene plasmid as a template, perform polymerase chain reaction to amplify the target fragment (TAKARA company), recover the target fragment from the kit (Shanghai Sangon Bioengineering Co., Ltd.), enzyme The excised fragment and the vector were ligated with T4 DNA Ligase, o...

Embodiment 2

[0024] Embodiment 2: virus transduction HeLa cell

[0025] The collected supernatant contains the recombinant COMP lentivirus, and the packaged virus is used to further transduce HeLa cells, and the stably transfected cell lines are screened. The specific operations are as follows:

[0026] HeLa cells were plated in 6-well plates 24 h before transduction, and when the cells adhered to the wall and grew to about 80%, the old medium was sucked off, and fresh MEM medium (10% fetal bovine serum, 1% Penicillin- Streptomycin) 1.8 mL, recombinant COMP lentivirus 200 μL, and Hexadimethrine bromide (transfection enhancer) 1.6 μL, mixed gently, and cultured in an incubator at 37 °C with 5% CO2;

[0027] After 24 h, the medium containing the virus was sucked off, and 2 mL of fresh medium was replaced, and the culture was continued;

[0028] After 48 h, replace the medium, add 2 mL of fresh medium and add Puromycin (2 μg / mL);

[0029] Afterwards, the medium (containing puro) was changed e...

Embodiment 3

[0031] Example 3: Evaluation of the intracellular COMP content of a cell model using a fluorescence spectrophotometer

[0032] In the stably transfected HeLa cell line, COMP protein and eGFP are fused and expressed, so the content of COMP protein can be indirectly reflected by detecting the content of GFP.

[0033] We used the Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies) to detect the content of GFP. Initially, we found that GFP can best reflect the relative fluorescence intensity of GFP when the excitation wavelength is 485 nm and the emission wavelength is 530 nm.

[0034] We collected wild-type and mutant cells and cell culture fluid, diluted them with Tris-EDTA solution, and measured the fluorescence intensity of GFP using Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies). The results were analyzed using the ratio of GFP in cells and GFP in cell culture fluid Ratio to represent changes in intracellular COMP.

[0035] The results show...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of cell biology, and aims at the defect that protein misfolding cannot be quantitatively evaluated in real time in living cells at present, and provides a method for constructing a cell model for screening antioxidant drugs based on protein misfolding. Construction of fluorescent protein-tagged wild and mutant reporter genes COMP Gene lentiviral vector, virus packaging in human embryonic kidney 293T cells, transduction of HeLa cells, puromycin screening to obtain a cell model stably expressing COMP protein. Establishing an international-level, self-innovated drug screening cell model will not only provide key parameters for future industrial research on protein misfolding drug screening, but also provide relevant scientific basis for sustainable research on solving major diseases. The cell model has the characteristics of high chromosomal integration, high fluorescence intensity, stable genetic traits, and sensitivity to antioxidant drugs. It is an ideal model for drug screening of protein misfolding.

Description

technical field [0001] The invention belongs to the field of cell biology, and in particular relates to a method for constructing a cell model for screening antioxidant drugs based on protein misfolding. Background technique [0002] Proteins are the executors of all functions in living organisms. Any function in the human body, from catalyzing chemical reactions to defending against foreign aggressors, is the result of proteins. Proteins must fold precisely into the correct three-dimensional structure to function in human cells. In recent years, it has been found that protein misfolding can lead to some diseases. The relationship between protein misfolding and disease has become a new research frontier in molecular biology. Constructing a simple, safe and efficient drug screening cell model is the solution to the prevention and treatment of protein misfolding diseases such as Alzheimer's disease, Parkinson's disease, genetic bone disease and phenylketonuria, which are po...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/10C12N15/867C12N15/65C12N15/12C12Q1/02G01N21/64
CPCC07K14/47C12N15/65C12N15/86C12N2740/15043G01N21/6428G01N33/5044
Inventor 肖涵王晶吴长新
Owner SHANXI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com